A carregar...
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Orlistat, a weight-loss agent with a novel mechanism of action, recently was approved by the Food and Drug Administration for the treatment of obesity. It inhibits gastric and pancreatic lipases in the lumen of the gastrointestinal tract to decrease systemic absorption of dietary fat. In several tri...
Na minha lista:
| Publicado no: | Pharmacotherapy |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6145169/ https://ncbi.nlm.nih.gov/pubmed/10730683 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|